Search Results - "Bass, Amr K. A."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Application of quality-by-design for adopting an environmentally green fluorogenic determination of benoxinate hydrochloride in eye drops and artificial aqueous humour by El Hamd, Mohamed A., El-Maghrabey, Mahmoud, Magdy, Galal, Mahdi, Wael A., Alshehri, Sultan, Bass, Amr K. A., Batakoushy, Hany A.

    Published in Scientific reports (26-05-2023)
    “…Herein, a sensitive and selective spectrofluorimetric method has been developed for the determination of the ocular local anesthetic benoxinate hydrochloride…”
    Get full text
    Journal Article
  2. 2

    New Pyrimidine-5-Carbonitriles as COX-2 Inhibitors: Design, Synthesis, Anticancer Screening, Molecular Docking, and In Silico ADME Profile Studies by AL-Ghulikah, Hanan A, El-Sebaey, Samiha A, Bass, Amr K. A, El-Zoghbi, Mona S

    Published in Molecules (Basel, Switzerland) (01-11-2022)
    “…Two series of cyanopyrimidine hybrids were synthesized bearing either benzo[d]imidazole, benzo[d]oxazole, benzo[d]thiazole, and benzo[b]thiophene derivatives…”
    Get full text
    Journal Article
  3. 3

    Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors by Bass, Amr K.A., El-Zoghbi, Mona S., Nageeb, El-Shimaa M., Mohamed, Mamdouh F.A., Badr, Mohamed, Abuo-Rahma, Gamal El-Din A.

    Published in European journal of medicinal chemistry (01-01-2021)
    “…Despite the encouraging clinical progress of chemotherapeutic agents in cancer treatment, innovation and development of new effective anticancer candidates…”
    Get full text
    Journal Article
  4. 4

    Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy by Soltan, Osama M., Abdelrahman, Kamal S., Bass, Amr K.A., Takizawa, Kazuki, Narumi, Atsushi, Konno, Hiroyuki

    Published in Bioorganic chemistry (01-10-2024)
    “…[Display omitted] •The HDACs ability to synergistically boost the performance of other anti-AD drugs, as well as the ease with which HDACs inhibitor cap group,…”
    Get full text
    Journal Article
  5. 5

    Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives by Marzouk, Adel A., Bass, Amr K.A., Ahmed, Montaser Sh, Abdelhamid, Antar A., Elshaier, Yaseen A.M.M., Salman, Asmaa M.M., Aly, Omar M.

    Published in Bioorganic chemistry (01-08-2020)
    “…[Display omitted] •New imidazolidindione and tetrasubstituted imidazole derivatives were synthesized and structurally approved.•The anticonvulsant activity of…”
    Get full text
    Journal Article
  6. 6

    Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors by Bass, Amr K.A., Nageeb, El-Shimaa M., El-Zoghbi, Mona S., Mohamed, Mamdouh F.A., Badr, Mohamed, Abuo-Rahma, Gamal El-Din A.

    Published in Bioorganic chemistry (01-02-2022)
    “…[Display omitted] •Twenty-one cyanopyridine derivatives were designed as PIM-1/HDAC inhibitors.•3b, 3c, 4d, 4e, 4b and 4g showed the most active activity…”
    Get full text
    Journal Article